Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M201-A-CT-004
jRCT2031240034Not yet recruiting
- Sponsor
- Aetas Pharma Inc.
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in heart failure (HF) comparing M201-A hydrochloride IV arm with Placebo IV arm (2 arms). Primary endpoints: Safety: adverse events and side effects, Safety: vital signs and 21 more. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
m201-a
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on jRCT2031240034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240034.